California Appeals Court Reverses Summary Judgment In Diabetes Drug Case
(November 7, 2018, 10:42 AM EST) -- LOS ANGELES — A California state appeals court on Nov. 6 reversed summary judgment for three drug makers in the state’s coordinated incretin mimetic diabetes drug litigation, saying the trial court...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login